Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-27 Option Award | 2024-11-27 5:10 pm | N/A 2034-11-27 | ENANTA PHARMACEUTICALS INC | ENTA | Kowalsky Matthew Paul Chief Legal Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-04-29 Option Award | 2024-05-01 4:27 pm | N/A 2034-04-29 | ENANTA PHARMACEUTICALS INC | ENTA | Kowalsky Matthew Paul Chief Legal Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO | 1,925 | $0 | 0 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO | 12,690 | $0.75 | 0 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-01 4:46 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO | 165,000 | $0 | 165,000 (Direct) | View |
Ownership | 2023-03-01 4:35 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO | 0 | $0 | 343,570 (Direct) | View |